ArticleKidney medicine2026
Kidney Failure in Persons With Cystic Fibrosis.
Article in Kidney medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Rationale & Objectives: Chronic kidney disease (CKD) occurs with increased frequency in people with cystic fibrosis (PwCF). CKD may progress to kidney failure. We sought to describe the prevalence, characteristics, and outcomes of kidney failure in PwCF. Study Design: Retrospective cohort study using data supplied by the US Renal Data System (USRDS), a virtually complete record of all US persons with kidney failure. Setting & Participants: All unique deidentified persons listed in the USRDS patient and hospitalization Standard Analytic Files from 2014 through 2018. Outcomes: Estimated prevalence of kidney failure in PwCF and non-CF cohorts. Comparisons between PwCF and people without CF concerning demographic characteristics, primary cause of kidney failure, diabetes, organ transplant status, mortality, and survival since the onset of kidney failure. Analytical Approach: Linear and logistic regression, propensity score-matched Kaplan-Meier survival curves, and log-rank tests. Results: We estimated the prevalence of kidney failure requiring dialysis or transplantation to be 22.6-29.3 times greater in PwCF than in the general US population. Diabetes was the primary cause of kidney failure in 24.3% of PwCF and 42.3% of people without CF (odds ratio, 0.56; 95% CI, 0.44-0.71; Limitations: USRDS data are limited to Medicare claims. Conclusions: PwCF had an increased prevalence of kidney failure relative to the non-CF US population. The profile of primary causes of kidney failure in PwCF differed from that in the non-CF population. Diabetes was half as frequent, and transplants of lungs and other organs were markedly more frequent primary causes in PwCF. Overall median survival of patients with kidney failure was not significantly different between PwCF and matched people without CF.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.